Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01566214
Other study ID # PPO 09-283
Secondary ID 200910778
Status Completed
Phase Phase 2
First received
Last updated
Start date April 30, 2012
Est. completion date October 31, 2012

Study information

Verified date June 2018
Source VA Office of Research and Development
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research study is to survey patients to learn about their beliefs and behaviors related to the management of heart disease and to discuss options for making healthy lifestyle changes. From the information the investigators get from patients, the investigators hope to develop better methods for taking care of patients who have heart disease.


Description:

Coronary heart disease (CHD) is a significant health threat among veterans. Compared to their civilian counterparts, veterans experience greater disability, reinfarction, and mortality following myocardial infarction (MI) and other acute coronary syndromes (ACS). High rates of hypertension, diabetes, and cardiac risk behaviors (e.g., smoking) and low socioeconomic status (SES) further increase veterans' CHD-related morbidity and mortality. The proposed pilot project will establish the feasibility of a telehealth nursing intervention for veterans with CHD who are recovering from MI/ACS. The Veterans Heart Attack Representations Telehealth (Vet-HART) intervention is designed to promote adaptive conceptual change in veterans' beliefs (common sense models or representations) about CHD etiology and self-management and facilitate health behavior changes (e.g., smoking cessation, medication adherence, diet management, and increased physical activity). The long-term goal of this research program is to improve veterans' quality of life (QoL) and reduce their CHD-related morbidity/mortality. The proposed project is the requisite next step in attaining that goal.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date October 31, 2012
Est. primary completion date June 30, 2012
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Admission to an inpatient medicine unit for MI, ACS, and coronary angiography

- Age

Exclusion Criteria:

- Altered mental status

- Language barriers

- Dementia or Cognitive Impairment

- Diagnostic Study

- Resident in long-term care facility prior to the present admission

- Planned discharge to a skilled or intermediate care facility or hospice

- Lack of access to a functioning phone

Study Design


Intervention

Behavioral:
Motivational Interview
For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes.

Locations

Country Name City State
United States Iowa City VA Health Care System, Iowa City, IA Iowa City Iowa

Sponsors (2)

Lead Sponsor Collaborator
VA Office of Research and Development University of Iowa

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary SF-36v Physical Function Scale Physical Functioning Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. Change from baseline to 3-months post hospital discharge
Primary SF-36v Role Limitations Due to Physical Health Scale Role Limitations Due to Physical Health Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. Change from baseline to 3-months post hospital discharge
Primary SF-36v Role Limitations Due to Emotional Problems Scale Role Limitations Due to Emotional Problems Scale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. Change from baseline to 3-months post hospital discharge
Primary SF-36v Energy-Fatigue Scale Energy-Fatigue Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. Change from baseline to 3-months post hospital discharge
Primary SF-36v Emotional Well-Being Scale Emotional Well-Being Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. Change from baseline to 3-months post hospital discharge
Primary SF-36v Social Functioning Scale Social Functioning Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. Change from baseline to 3-months post hospital discharge
Primary SF-36v Pain Scale Pain Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. Change from baseline to 3-months post hospital discharge
Primary SF-36v General Health Scale General Health Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. Change from baseline to 3-months post hospital discharge
Primary Seattle Angina Questionnaire Physical Limitations Scale Physical Limitations Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. Change from baseline to 3-months post hospital discharge
Primary Seattle Angina Questionnaire Angina Stability Scale Angina Stability Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. Change from baseline to 3-months post hospital discharge
Primary Seattle Angina Questionnaire Angina Frequency Scale Angina Frequency Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. Change from baseline to 3-months post hospital discharge
Primary Seattle Angina Questionnaire Treatment Satisfaction Scale Treatment Satisfaction Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. Change from baseline to 3-months post hospital discharge
Primary Seattle Angina Questionnaire Disease Perception Scale Disease Perception Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. Change from baseline to 3-months post hospital discharge
See also
  Status Clinical Trial Phase
Completed NCT03481322 - Low Sodium Cooking Study N/A
Completed NCT00001638 - Magnetic Resonance Imaging of the Blood Vessels of the Heart
Completed NCT02376244 - The Health Impact of High Intensity Exercise Training With Intervals During Cardiac Rehabilitation N/A
Completed NCT02523144 - Dexmedetomidine in Children Having Transthoracic Echocardiography Phase 4
Completed NCT02277379 - Prediction of Bleeding and Transfusion Outcomes and Assessment of Perioperative Platelet Reactivity in Cardiac Surgery N/A
Completed NCT01871090 - Remote Device Interrogation In The Emergency Department N/A
Completed NCT02045641 - Pleural and Pericardial Effusion Following Open Heart Surgery N/A
Active, not recruiting NCT01400490 - Eicosapentaenoic Acid (EPA)and Docosahexaenoic Acid Study N/A
Completed NCT01192360 - Dynamic Contrast Enhanced Magnetic Resonance Perfusion Imaging in Congenital Heart Disease and Lung Disease Phase 3
Terminated NCT00935766 - Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries Phase 3
Completed NCT00745446 - The Effect of a Retrofit Particle Trap on the Vascular Effects of Diesel Exhaust Inhalation N/A
Completed NCT00140816 - Dairy Products and Metabolic Effects (Norwegian Part) N/A
Completed NCT00178620 - Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization Phase 4
Completed NCT00013949 - Cardiovascular Vulnerability to Particulate Exposure N/A
Completed NCT01952171 - The Genetic Basis of Congenital Heart Disease in Africa
Recruiting NCT02933892 - Benefit of Transradial Approach in Chronic Kidney Disease Population Undergoing Cardiac Catheterization Phase 4
Withdrawn NCT02838355 - Employing End Tidal Capnography in Continuous Flow Ventricular Assist Device Patients N/A
Completed NCT02923518 - Cardiac Screening of Middle Aged and Older Women and Men (Master Athletes)
Terminated NCT02282163 - Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography Phase 3
Active, not recruiting NCT02260466 - Prevalence and Post-surgical Outcomes of CARdiac Wild-type TransthyrEtin amyloidoSIs in Elderly Patients With Aortic steNosis Referred for Valvular Replacement. N/A